|
Midazolam Clinical Trials
10 actively recruiting trials across 4 locations
▲ +1 trial since May 2026
Also known as: Dormicum, Hypnovel, Randomized Controlled Phase Intervention 2, Seizalam
Pipeline
Phase 1: 2Phase 3: 2Phase 4: 1Phase 1/2: 1
Top Sponsors
- Yangzhou University1
- University Hospital, Montpellier1
- Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital1
- Pfizer1
- Nuvalent Inc.1
Indications
- Anxiety4
- Cancer3
- Heart Disease2
- Pediatric Anesthesia1
- Emergence Agitation1
Other6 trials
Phase 3
Birmingham, Alabama1 trial
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
University of Alabama at Birmingham
Phase 3
Fayetteville, Arkansas1 trial
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
Highlands Oncology Group
Phase 1
Orange, California1 trial
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
University of California Irvine Medical Center
Phase 1/2
Glenview, Illinois1 trial
Phase 4
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.